BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10662956)

  • 1. The contribution of (1)H-magnetic resonance spectroscopy in defining the pathophysiology of multiple sclerosis.
    Simone IL; Tortorella C; Federico F
    Ital J Neurol Sci; 1999; 20(5 Suppl):S241-5. PubMed ID: 10662956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.
    Simone IL; Tortorella C; Federico F; Liguori M; Lucivero V; Giannini P; Carrara D; Bellacosa A; Livrea P
    J Neurol Sci; 2001 Jan; 182(2):143-50. PubMed ID: 11137520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging axonal damage of normal-appearing white matter in multiple sclerosis.
    Fu L; Matthews PM; De Stefano N; Worsley KJ; Narayanan S; Francis GS; Antel JP; Wolfson C; Arnold DL
    Brain; 1998 Jan; 121 ( Pt 1)():103-13. PubMed ID: 9549491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton MR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression, and evaluating therapy.
    Richards TL
    AJR Am J Roentgenol; 1991 Nov; 157(5):1073-8. PubMed ID: 1927795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.
    Barkhof F; van Walderveen M
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1675-86. PubMed ID: 10603619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance spectroscopy of memory and frontal brain region in early multiple sclerosis.
    Staffen W; Zauner H; Mair A; Kutzelnigg A; Kapeller P; Stangl H; Raffer E; Niederhofer H; Ladurner G
    J Neuropsychiatry Clin Neurosci; 2005; 17(3):357-63. PubMed ID: 16179658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis.
    De Stefano N; Narayanan S; Matthews PM; Francis GS; Antel JP; Arnold DL
    Brain; 1999 Oct; 122 ( Pt 10)():1933-9. PubMed ID: 10506094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy.
    Bitsch A; Bruhn H; Vougioukas V; Stringaris A; Lassmann H; Frahm J; Brück W
    AJNR Am J Neuroradiol; 1999 Oct; 20(9):1619-27. PubMed ID: 10543631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability.
    De Stefano N; Narayanan S; Francis GS; Arnaoutelis R; Tartaglia MC; Antel JP; Matthews PM; Arnold DL
    Arch Neurol; 2001 Jan; 58(1):65-70. PubMed ID: 11176938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton MR spectroscopy and magnetization transfer ratio in multiple sclerosis: correlative findings of active versus irreversible plaque disease.
    Kimura H; Grossman RI; Lenkinski RE; Gonzalez-Scarano F
    AJNR Am J Neuroradiol; 1996 Sep; 17(8):1539-47. PubMed ID: 8883654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axonal damage but no increased glial cell activity in the normal-appearing white matter of patients with clinically isolated syndromes suggestive of multiple sclerosis using high-field magnetic resonance spectroscopy.
    Wattjes MP; Harzheim M; Lutterbey GG; Klotz L; Schild HH; Träber F
    AJNR Am J Neuroradiol; 2007 Sep; 28(8):1517-22. PubMed ID: 17846203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance spectroscopy of normal appearing white matter in early relapsing-remitting multiple sclerosis: correlations between disability and spectroscopy.
    Ruiz-Peña JL; Piñero P; Sellers G; Argente J; Casado A; Foronda J; Uclés A; Izquierdo G
    BMC Neurol; 2004 Jun; 4():8. PubMed ID: 15191618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.
    De Stefano N; Matthews PM; Fu L; Narayanan S; Stanley J; Francis GS; Antel JP; Arnold DL
    Brain; 1998 Aug; 121 ( Pt 8)():1469-77. PubMed ID: 9712009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
    Pardini M; Botzkowski D; Müller S; Vehoff J; Kuhle J; Ruberte E; Würfel J; Gass A; Valmaggia C; Tettenborn B; Putzki N; Yaldizli Ö
    Eur J Neurol; 2016 Dec; 23(12):1769-1774. PubMed ID: 27591406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of spectroscopy and magnetization transfer imaging in the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosis.
    Hiehle JF; Lenkinski RE; Grossman RI; Dousset V; Ramer KN; Schnall MD; Cohen JA; Gonzalez-Scarano F
    Magn Reson Med; 1994 Sep; 32(3):285-93. PubMed ID: 7984060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis.
    Brex PA; Gomez-Anson B; Parker GJ; Molyneux PD; Miszkiel KA; Barker GJ; MacManus DG; Davie CA; Plant GT; Miller DH
    J Neurol Sci; 1999 Jun; 166(1):16-22. PubMed ID: 10465494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter.
    Narayanan S; Francis SJ; Sled JG; Santos AC; Antel S; Levesque I; Brass S; Lapierre Y; Sappey-Marinier D; Pike GB; Arnold DL
    Neuroimage; 2006 Jan; 29(2):637-42. PubMed ID: 16126413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axonal dysfunction and disability in a relapse of multiple sclerosis: longitudinal study of a patient.
    De Stefano N; Matthews PM; Narayanan S; Francis GS; Antel JP; Arnold DL
    Neurology; 1997 Oct; 49(4):1138-41. PubMed ID: 9339704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corpus callosum axonal injury in multiple sclerosis measured by proton magnetic resonance spectroscopic imaging.
    Oh J; Pelletier D; Nelson SJ
    Arch Neurol; 2004 Jul; 61(7):1081-6. PubMed ID: 15262739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study.
    Appenzeller S; Li LM; Costallat LT; Cendes F
    Brain; 2005 Dec; 128(Pt 12):2933-40. PubMed ID: 16195241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.